The Drug Enforcement Administration (DEA) has issued new requirements for new or renewing DEA licenses starting on June 27, 2023. With these new requirements, all applicants and renewals must have at least one of the following:

• A total of eight hours of training from certain organizations on opioid or other substance use disorders for practitioners renewing or newly applying for a registration from the DEA to prescribe any Schedule II-V controlled medications.
• Board certification in addiction medicine or addiction psychiatry from the American Board of Medical Specialties, American Board of Addiction Medicine, or the American Osteopathic Association; or
• Graduation within five years and status in good standing from medical, advanced practice nursing, or physician assistant school in the United States that included successful completion of an opioid or other substance use disorder curriculum of at least eight hours.

If you do not meet one of the criteria above, it is important to note that there is no time limitation on previous training. This means that if you have taken any ERLA or Prescribing Controlled Substances lectures at VOMA conferences, they will count towards your eight hours of required training. The certificates that were issued at those conferences specify how many “Opioid Prescribing and Monitoring of Controlled Substances” credits you earned at the conference, so please refer to these certificates to determine if you need further training.

If you are in need of further training, VOMA has a bundle of 3 courses that will satisfy 6 of the required 8 hours available for purchase ($175 for members, $225 for non-members). Please follow this link to register for access to these three on-demand courses: https://voma.memberclicks.net/dearequiredcme

You are encouraged to keep a record of your certificates for documentation purposes.

Additional Resources Resources

The Medication Access and Training Expansion (MATE) Act | ACCME